| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | CD8 receptor binding | 1.39e-09 | 9 | 131 | 5 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP complex binding | 1.39e-09 | 9 | 131 | 5 | GO:0062061 | |
| GeneOntologyMolecularFunction | TAP1 binding | 2.76e-09 | 10 | 131 | 5 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 2.76e-09 | 10 | 131 | 5 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 2.76e-09 | 10 | 131 | 5 | GO:0046977 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 8.59e-09 | 12 | 131 | 5 | GO:0030881 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 6.54e-08 | 17 | 131 | 5 | GO:0046703 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 1.61e-07 | 20 | 131 | 5 | GO:0042608 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 1.97e-06 | 32 | 131 | 5 | GO:0042288 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 7.88e-06 | 42 | 131 | 5 | GO:0071889 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 1.70e-05 | 49 | 131 | 5 | GO:0042605 | |
| GeneOntologyMolecularFunction | MHC protein binding | 3.90e-05 | 58 | 131 | 5 | GO:0042287 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 4.38e-05 | 11 | 131 | 3 | GO:0005388 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.45e-04 | 16 | 131 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | calcium-dependent ATPase activity | 2.54e-04 | 4 | 131 | 2 | GO:0030899 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 3.37e-04 | 21 | 131 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | YTHDC2 CHD1L HELB MDN1 MACF1 KIF13A ATP2A1 ATP2A2 ATP2A3 DNAH8 | 6.68e-04 | 441 | 131 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | protein-folding chaperone binding | 6.82e-04 | 161 | 131 | 6 | GO:0051087 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | YTHDC2 CHD1L XRCC2 HELB MDN1 STARD9 MACF1 KIF13A ATP2A1 ATP2A2 ATP2A3 DNAH8 | 7.31e-04 | 614 | 131 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | peptide binding | 1.21e-03 | 318 | 131 | 8 | GO:0042277 | |
| GeneOntologyMolecularFunction | galactoside binding | 1.49e-03 | 9 | 131 | 2 | GO:0016936 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 1.68e-03 | 36 | 131 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 1.68e-03 | 36 | 131 | 3 | GO:0015662 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 2.12e-03 | 39 | 131 | 3 | GO:0070325 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 5.70e-10 | 8 | 133 | 5 | GO:0002485 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 4.26e-08 | 16 | 133 | 5 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 6.01e-08 | 17 | 133 | 5 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 6.01e-08 | 17 | 133 | 5 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 8.28e-08 | 18 | 133 | 5 | GO:0002428 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 8.28e-08 | 18 | 133 | 5 | GO:0042590 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 3.17e-07 | 23 | 133 | 5 | GO:0019885 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 4.95e-07 | 25 | 133 | 5 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 4.95e-07 | 25 | 133 | 5 | GO:0002475 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 1.81e-06 | 32 | 133 | 5 | GO:0019883 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 6.43e-06 | 41 | 133 | 5 | GO:0002474 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 7.26e-06 | 42 | 133 | 5 | GO:0001916 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | RELN HLA-A NRDC HLA-B HLA-C KALRN NTRK1 HLA-G HLA-H RETREG3 LRP8 TRIM67 LRP1 MACF1 NIN | 9.84e-06 | 612 | 133 | 15 | GO:0010975 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 1.42e-05 | 48 | 133 | 5 | GO:0002478 | |
| GeneOntologyBiologicalProcess | protection from natural killer cell mediated cytotoxicity | 2.14e-05 | 9 | 133 | 3 | GO:0042270 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 2.31e-05 | 53 | 133 | 5 | GO:0001914 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation | 3.33e-05 | 139 | 133 | 7 | GO:0019882 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum calcium ion homeostasis | 3.46e-05 | 29 | 133 | 4 | GO:0032469 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 3.60e-05 | 58 | 133 | 5 | GO:0019884 | |
| GeneOntologyBiologicalProcess | calcium ion transport from cytosol to endoplasmic reticulum | 4.13e-05 | 2 | 133 | 2 | GO:1903515 | |
| GeneOntologyBiologicalProcess | neuron projection development | PRTG RELN HLA-A NRDC HLA-B HLA-C KALRN NTRK1 HLA-G HLA-H GPRIN3 EXT1 ADGRV1 RETREG3 LRP8 STRN TRIM67 UNC5C LRP1 MACF1 NIN | 7.41e-05 | 1285 | 133 | 21 | GO:0031175 |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 8.57e-05 | 418 | 133 | 11 | GO:0051962 | |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity | 8.94e-05 | 70 | 133 | 5 | GO:0001913 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 1.02e-04 | 354 | 133 | 10 | GO:0050769 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | RELN HLA-A NRDC HLA-B HLA-C KALRN NTRK1 HLA-G HLA-H RETREG3 LRP8 TRIM67 TBC1D14 LRP1 MACF1 NIN | 1.12e-04 | 846 | 133 | 16 | GO:0120035 |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immunity | 1.17e-04 | 74 | 133 | 5 | GO:0002711 | |
| GeneOntologyBiologicalProcess | positive regulation of endoplasmic reticulum calcium ion concentration | 1.23e-04 | 3 | 133 | 2 | GO:0032470 | |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 1.23e-04 | 3 | 133 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.26e-04 | 40 | 133 | 4 | GO:0045953 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 1.32e-04 | 76 | 133 | 5 | GO:0048002 | |
| GeneOntologyBiologicalProcess | oligosaccharide catabolic process | 1.38e-04 | 16 | 133 | 3 | GO:0009313 | |
| GeneOntologyBiologicalProcess | regulation of dendritic cell differentiation | 1.38e-04 | 16 | 133 | 3 | GO:2001198 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.39e-04 | 41 | 133 | 4 | GO:0002716 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | RELN HLA-A NRDC HLA-B HLA-C KALRN NTRK1 HLA-G HLA-H RETREG3 LRP8 TRIM67 TBC1D14 LRP1 MACF1 NIN | 1.41e-04 | 863 | 133 | 16 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 1.54e-04 | 124 | 133 | 6 | GO:0001910 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated cytotoxicity | 1.59e-04 | 79 | 133 | 5 | GO:0001912 | |
| GeneOntologyBiologicalProcess | neuron development | PRTG RELN PDE6C HLA-A NRDC HLA-B HLA-C KALRN NTRK1 HLA-G HLA-H GPRIN3 EXT1 ADGRV1 RETREG3 LRP8 STRN TRIM67 UNC5C LRP1 MACF1 NIN | 1.64e-04 | 1463 | 133 | 22 | GO:0048666 |
| GeneOntologyBiologicalProcess | positive regulation of cell development | RELN NRDC KALRN HLA-G XRCC2 LRP8 LGALS9 TGM2 NCAN BTN2A3P LRP1 MACF1 NIN | 1.73e-04 | 614 | 133 | 13 | GO:0010720 |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 2.38e-04 | 47 | 133 | 4 | GO:0001911 | |
| GeneOntologyBiologicalProcess | disaccharide catabolic process | 2.46e-04 | 4 | 133 | 2 | GO:0046352 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 2.46e-04 | 4 | 133 | 2 | GO:0008049 | |
| GeneOntologyBiologicalProcess | positive regulation of cell killing | 2.64e-04 | 88 | 133 | 5 | GO:0031343 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | 3.15e-04 | 333 | 133 | 9 | GO:0051056 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 3.52e-04 | 52 | 133 | 4 | GO:0031342 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 3.86e-04 | 147 | 133 | 6 | GO:0031341 | |
| GeneOntologyBiologicalProcess | cytosol to endoplasmic reticulum transport | 4.07e-04 | 5 | 133 | 2 | GO:0046967 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 4.80e-04 | 24 | 133 | 3 | GO:0071625 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 5.15e-04 | 515 | 133 | 11 | GO:0050767 | |
| GeneOntologyBiologicalProcess | T cell mediated immunity | 6.67e-04 | 163 | 133 | 6 | GO:0002456 | |
| GeneOntologyBiologicalProcess | positive regulation of viral life cycle | 6.85e-04 | 27 | 133 | 3 | GO:1903902 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | PRTG RELN NRDC KALRN NTRK1 XRCC2 LRP8 TGM2 NCAN LRP1 MACF1 NIN | 7.37e-04 | 625 | 133 | 12 | GO:0051960 |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immunity | 7.67e-04 | 111 | 133 | 5 | GO:0002709 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 8.05e-04 | 169 | 133 | 6 | GO:0010977 | |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 8.47e-04 | 29 | 133 | 3 | GO:1903779 | |
| GeneOntologyBiologicalProcess | courtship behavior | 8.48e-04 | 7 | 133 | 2 | GO:0007619 | |
| GeneOntologyBiologicalProcess | calcium ion import into sarcoplasmic reticulum | 8.48e-04 | 7 | 133 | 2 | GO:1990036 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 8.65e-04 | 114 | 133 | 5 | GO:0045824 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 2.01e-10 | 7 | 133 | 5 | GO:0032398 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 2.37e-09 | 10 | 133 | 5 | GO:0042612 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 1.85e-08 | 14 | 133 | 5 | GO:0042824 | |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 5.63e-08 | 17 | 133 | 5 | GO:0033106 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 2.97e-07 | 23 | 133 | 5 | GO:0005797 | |
| GeneOntologyCellularComponent | MHC protein complex | 5.71e-07 | 26 | 133 | 5 | GO:0042611 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 2.69e-06 | 35 | 133 | 5 | GO:0098553 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 6.81e-06 | 42 | 133 | 5 | GO:0070971 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 1.33e-05 | 48 | 133 | 5 | GO:0098576 | |
| GeneOntologyCellularComponent | cis-Golgi network | 1.72e-05 | 85 | 133 | 6 | GO:0005801 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 2.06e-05 | 9 | 133 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | cell surface | HLA-A NRDC HLA-B HLA-C NLGN4Y NTRK1 HLA-G HLA-H MCAM ADGRV1 LCT PTGFRN LRP8 TYRO3 NLGN4X UMODL1 UNC5C BTN2A3P LRP1 AGAP2 | 2.43e-05 | 1111 | 133 | 20 | GO:0009986 |
| GeneOntologyCellularComponent | Golgi cisterna | 2.54e-05 | 135 | 133 | 7 | GO:0031985 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 4.00e-05 | 11 | 133 | 3 | GO:0031094 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 5.46e-05 | 64 | 133 | 5 | GO:0012507 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 8.16e-05 | 112 | 133 | 6 | GO:0055038 | |
| GeneOntologyCellularComponent | recycling endosome | 8.96e-05 | 222 | 133 | 8 | GO:0055037 | |
| GeneOntologyCellularComponent | Golgi stack | 1.14e-04 | 171 | 133 | 7 | GO:0005795 | |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 1.89e-04 | 83 | 133 | 5 | GO:0030670 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 2.39e-04 | 4 | 133 | 2 | GO:0098983 | |
| GeneOntologyCellularComponent | glycinergic synapse | 2.65e-04 | 20 | 133 | 3 | GO:0098690 | |
| GeneOntologyCellularComponent | early endosome membrane | 4.23e-04 | 212 | 133 | 7 | GO:0031901 | |
| GeneOntologyCellularComponent | external side of plasma membrane | HLA-A HLA-B HLA-C HLA-G HLA-H MCAM LCT UMODL1 BTN2A3P LRP1 AGAP2 | 4.92e-04 | 519 | 133 | 11 | GO:0009897 |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | HLA-A HLA-B HLA-C HLA-G HLA-H WDR11 GOLIM4 B4GALNT3 KIF13A PCSK4 | 5.48e-04 | 443 | 133 | 10 | GO:0098791 |
| GeneOntologyCellularComponent | postsynaptic density | KALRN NLGN4Y LRP8 SLC6A9 STRN GRK2 NLGN4X ARHGEF9 LRP1 MACF1 | 6.29e-04 | 451 | 133 | 10 | GO:0014069 |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 6.94e-04 | 110 | 133 | 5 | GO:0030134 | |
| GeneOntologyCellularComponent | asymmetric synapse | KALRN NLGN4Y LRP8 SLC6A9 STRN GRK2 NLGN4X ARHGEF9 LRP1 MACF1 | 9.65e-04 | 477 | 133 | 10 | GO:0032279 |
| GeneOntologyCellularComponent | early endosome | 1.03e-03 | 481 | 133 | 10 | GO:0005769 | |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 1.23e-03 | 125 | 133 | 5 | GO:0140534 | |
| GeneOntologyCellularComponent | postsynaptic specialization | KALRN NLGN4Y LRP8 SLC6A9 STRN GRK2 NLGN4X ARHGEF9 LRP1 MACF1 | 1.44e-03 | 503 | 133 | 10 | GO:0099572 |
| GeneOntologyCellularComponent | centriolar subdistal appendage | 1.75e-03 | 10 | 133 | 2 | GO:0120103 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | KALRN NLGN4Y LRP8 SLC6A9 STRN GRK2 NLGN4X ARHGEF9 LRP1 MACF1 | 1.91e-03 | 523 | 133 | 10 | GO:0098984 |
| GeneOntologyCellularComponent | membrane raft | 2.25e-03 | 362 | 133 | 8 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 2.33e-03 | 364 | 133 | 8 | GO:0098857 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 2.39e-03 | 212 | 133 | 6 | GO:0030666 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 2.74e-03 | 293 | 133 | 7 | GO:0030658 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 2.94e-03 | 45 | 133 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | symmetric synapse | 2.99e-03 | 13 | 133 | 2 | GO:0032280 | |
| GeneOntologyCellularComponent | endosome | CCDC22 HLA-A HLA-B HLA-C NTRK1 HLA-G HLA-H APOC3 SLC6A9 NISCH TBC1D14 OSBPL6 LRP1 GOLIM4 KIF13A AGAP2 | 3.06e-03 | 1167 | 133 | 16 | GO:0005768 |
| GeneOntologyCellularComponent | dendrite | RELN NRDC NLGN4Y NTRK1 RGS12 LRP8 STRN GRK2 NLGN4X UNC5C LRP1 AGAP2 NIN | 3.28e-03 | 858 | 133 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | phagocytic vesicle | 3.33e-03 | 157 | 133 | 5 | GO:0045335 | |
| GeneOntologyCellularComponent | dendritic tree | RELN NRDC NLGN4Y NTRK1 RGS12 LRP8 STRN GRK2 NLGN4X UNC5C LRP1 AGAP2 NIN | 3.35e-03 | 860 | 133 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | vacuole | HLA-A HLA-B HLA-C HLA-G HLA-H USP5 NEU2 WDR11 TRIM17 NCAN TBC1D14 LRP1 BBC3 | 5.51e-03 | 913 | 133 | 13 | GO:0005773 |
| GeneOntologyCellularComponent | lysosome | HLA-A HLA-B HLA-C HLA-G HLA-H USP5 NEU2 WDR11 TRIM17 NCAN LRP1 BBC3 | 5.65e-03 | 811 | 133 | 12 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | HLA-A HLA-B HLA-C HLA-G HLA-H USP5 NEU2 WDR11 TRIM17 NCAN LRP1 BBC3 | 5.65e-03 | 811 | 133 | 12 | GO:0000323 |
| MousePheno | spinal cord inflammation | 1.81e-09 | 8 | 114 | 5 | MP:0030987 | |
| MousePheno | decreased immature NK cell number | 3.94e-06 | 14 | 114 | 4 | MP:0013666 | |
| MousePheno | decreased mature NK cell number | 1.18e-05 | 18 | 114 | 4 | MP:0013672 | |
| MousePheno | abnormal immature NK cell number | 1.48e-05 | 19 | 114 | 4 | MP:0013665 | |
| MousePheno | abnormal immature NK cell morphology | 1.48e-05 | 19 | 114 | 4 | MP:0013699 | |
| MousePheno | cystolithiasis | 2.74e-05 | 22 | 114 | 4 | MP:0011625 | |
| MousePheno | decreased susceptibility to autoimmune diabetes | 3.11e-05 | 45 | 114 | 5 | MP:0004804 | |
| MousePheno | abnormal mature NK cell number | 3.93e-05 | 24 | 114 | 4 | MP:0013671 | |
| MousePheno | abnormal mature NK cell morphology | 4.65e-05 | 25 | 114 | 4 | MP:0013700 | |
| MousePheno | demyelination | 6.68e-05 | 85 | 114 | 6 | MP:0000921 | |
| MousePheno | CNS inflammation | 7.60e-05 | 54 | 114 | 5 | MP:0006082 | |
| MousePheno | urolithiasis | 1.11e-04 | 31 | 114 | 4 | MP:0005360 | |
| Domain | MHC_I_a_C | 3.65e-08 | 6 | 133 | 4 | IPR010579 | |
| Domain | MHC_I_C | 3.65e-08 | 6 | 133 | 4 | PF06623 | |
| Domain | MHC_I | 3.15e-07 | 21 | 133 | 5 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 3.15e-07 | 21 | 133 | 5 | IPR001039 | |
| Domain | P-type_ATPase_IIA | 3.53e-07 | 3 | 133 | 3 | IPR005782 | |
| Domain | IG_LIKE | PRTG MYLK HLA-A HLA-B HLA-C KALRN NTRK1 HLA-G HLA-H MCAM PTGFRN TYRO3 NCAN UNC5C BTN2A3P MYOM2 | 4.32e-07 | 491 | 133 | 16 | PS50835 |
| Domain | Ig-like_dom | PRTG MYLK HLA-A HLA-B HLA-C KALRN NTRK1 HLA-G HLA-H MCAM PTGFRN TYRO3 NCAN UNC5C BTN2A3P MYOM2 | 5.96e-07 | 503 | 133 | 16 | IPR007110 |
| Domain | Ig-like_fold | PRTG MYLK HLA-A HLA-B HLA-C KALRN NTRK1 HLA-G HLA-H MCAM PTGFRN TYRO3 TGM2 TRIM67 UMODL1 NCAN UNC5C BTN2A3P MYOM2 | 6.23e-07 | 706 | 133 | 19 | IPR013783 |
| Domain | - | PRTG MYLK HLA-A HLA-B HLA-C KALRN NTRK1 HLA-G MCAM PTGFRN TYRO3 TGM2 TRIM67 UMODL1 NCAN UNC5C MYOM2 | 4.89e-06 | 663 | 133 | 17 | 2.60.40.10 |
| Domain | - | 2.34e-05 | 24 | 133 | 4 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 2.34e-05 | 24 | 133 | 4 | IPR011161 | |
| Domain | C1-set | 4.06e-05 | 54 | 133 | 5 | PF07654 | |
| Domain | Hydrolase_3 | 4.08e-05 | 10 | 133 | 3 | PF08282 | |
| Domain | IGc1 | 4.85e-05 | 56 | 133 | 5 | SM00407 | |
| Domain | DUF5050 | 5.03e-05 | 2 | 133 | 2 | IPR032485 | |
| Domain | NLGN4 | 5.03e-05 | 2 | 133 | 2 | IPR030025 | |
| Domain | DUF5050 | 5.03e-05 | 2 | 133 | 2 | PF16472 | |
| Domain | Ig/MHC_CS | 5.75e-05 | 58 | 133 | 5 | IPR003006 | |
| Domain | Ig_C1-set | 5.75e-05 | 58 | 133 | 5 | IPR003597 | |
| Domain | IG_MHC | 6.77e-05 | 60 | 133 | 5 | PS00290 | |
| Domain | Ldl_recept_b | 1.21e-04 | 14 | 133 | 3 | PF00058 | |
| Domain | LDLRB | 1.21e-04 | 14 | 133 | 3 | PS51120 | |
| Domain | MHC_I/II-like_Ag-recog | 1.50e-04 | 38 | 133 | 4 | IPR011162 | |
| Domain | LY | 1.51e-04 | 15 | 133 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.51e-04 | 15 | 133 | 3 | IPR000033 | |
| Domain | fn3 | 1.62e-04 | 162 | 133 | 7 | PF00041 | |
| Domain | ATPase_P-typ_TM_dom | 1.85e-04 | 16 | 133 | 3 | IPR023298 | |
| Domain | - | 1.85e-04 | 16 | 133 | 3 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_cation-transptr_C | 2.23e-04 | 17 | 133 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 2.23e-04 | 17 | 133 | 3 | PF00689 | |
| Domain | Cation_ATPase_N | 2.66e-04 | 18 | 133 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 2.66e-04 | 18 | 133 | 3 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 3.15e-04 | 19 | 133 | 3 | IPR004014 | |
| Domain | FN3 | 3.64e-04 | 185 | 133 | 7 | SM00060 | |
| Domain | EGF-like_dom | 4.17e-04 | 249 | 133 | 8 | IPR000742 | |
| Domain | Nlgn | 4.96e-04 | 5 | 133 | 2 | IPR000460 | |
| Domain | - | 4.96e-04 | 5 | 133 | 2 | 2.120.10.10 | |
| Domain | FN3 | 5.63e-04 | 199 | 133 | 7 | PS50853 | |
| Domain | EGF_Ca-bd_CS | 6.48e-04 | 97 | 133 | 5 | IPR018097 | |
| Domain | EGF_CA | 7.11e-04 | 99 | 133 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 7.44e-04 | 100 | 133 | 5 | PS00010 | |
| Domain | FN3_dom | 7.52e-04 | 209 | 133 | 7 | IPR003961 | |
| Domain | IG | 8.75e-04 | 421 | 133 | 10 | SM00409 | |
| Domain | Ig_sub | 8.75e-04 | 421 | 133 | 10 | IPR003599 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 9.68e-04 | 106 | 133 | 5 | IPR000152 | |
| Domain | GAF | 1.03e-03 | 7 | 133 | 2 | PF01590 | |
| Domain | PH | 1.28e-03 | 229 | 133 | 7 | PF00169 | |
| Domain | GAF | 1.37e-03 | 8 | 133 | 2 | IPR003018 | |
| Domain | GAF | 1.37e-03 | 8 | 133 | 2 | SM00065 | |
| Domain | EGF | 1.49e-03 | 235 | 133 | 7 | SM00181 | |
| Domain | IGc2 | 1.49e-03 | 235 | 133 | 7 | SM00408 | |
| Domain | EGF_3 | 1.49e-03 | 235 | 133 | 7 | PS50026 | |
| Domain | Ig_sub2 | 1.49e-03 | 235 | 133 | 7 | IPR003598 | |
| Domain | - | 1.51e-03 | 32 | 133 | 3 | 3.40.1110.10 | |
| Domain | - | 1.51e-03 | 32 | 133 | 3 | 2.70.150.10 | |
| Domain | Calx_beta | 1.75e-03 | 9 | 133 | 2 | IPR003644 | |
| Domain | - | 1.75e-03 | 9 | 133 | 2 | 3.30.450.40 | |
| Domain | Sialidases | 1.75e-03 | 9 | 133 | 2 | IPR011040 | |
| Domain | GAF_dom-like | 1.75e-03 | 9 | 133 | 2 | IPR029016 | |
| Domain | Calx-beta | 1.75e-03 | 9 | 133 | 2 | PF03160 | |
| Domain | EGF_CA | 1.81e-03 | 122 | 133 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.94e-03 | 124 | 133 | 5 | IPR001881 | |
| Domain | ATPase_P-typ_cyto_domN | 1.96e-03 | 35 | 133 | 3 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 2.12e-03 | 36 | 133 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 2.12e-03 | 36 | 133 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 2.12e-03 | 36 | 133 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.30e-03 | 37 | 133 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 2.30e-03 | 37 | 133 | 3 | PF00122 | |
| Domain | EGF_1 | 2.36e-03 | 255 | 133 | 7 | PS00022 | |
| Domain | Ig_I-set | 2.42e-03 | 190 | 133 | 6 | IPR013098 | |
| Domain | I-set | 2.42e-03 | 190 | 133 | 6 | PF07679 | |
| Domain | - | 2.68e-03 | 39 | 133 | 3 | 2.120.10.30 | |
| Domain | EGF-like_CS | 2.68e-03 | 261 | 133 | 7 | IPR013032 | |
| Domain | LDLR_class-A_CS | 2.88e-03 | 40 | 133 | 3 | IPR023415 | |
| Domain | EGF_2 | 2.92e-03 | 265 | 133 | 7 | PS01186 | |
| Domain | EGF_CA | 3.33e-03 | 86 | 133 | 4 | PF07645 | |
| Domain | SPRY | 3.47e-03 | 87 | 133 | 4 | SM00449 | |
| Domain | Carboxylesterase_B_CS | 3.73e-03 | 13 | 133 | 2 | IPR019819 | |
| Domain | Keratin_I | 3.78e-03 | 44 | 133 | 3 | IPR002957 | |
| Domain | PH | 3.80e-03 | 278 | 133 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 3.88e-03 | 279 | 133 | 7 | PS50003 | |
| Domain | PH_domain | 3.95e-03 | 280 | 133 | 7 | IPR001849 | |
| Domain | Ldl_recept_a | 4.03e-03 | 45 | 133 | 3 | PF00057 | |
| Domain | 6-blade_b-propeller_TolB-like | 4.29e-03 | 46 | 133 | 3 | IPR011042 | |
| Domain | - | 4.29e-03 | 46 | 133 | 3 | 4.10.400.10 | |
| Domain | CARBOXYLESTERASE_B_2 | 4.33e-03 | 14 | 133 | 2 | PS00941 | |
| Domain | ATPase_dyneun-rel_AAA | 4.33e-03 | 14 | 133 | 2 | IPR011704 | |
| Domain | COesterase | 4.33e-03 | 14 | 133 | 2 | PF00135 | |
| Domain | CarbesteraseB | 4.33e-03 | 14 | 133 | 2 | IPR002018 | |
| Domain | AAA_5 | 4.33e-03 | 14 | 133 | 2 | PF07728 | |
| Domain | SPRY | 4.57e-03 | 94 | 133 | 4 | PF00622 | |
| Domain | SPRY_dom | 4.57e-03 | 94 | 133 | 4 | IPR003877 | |
| Domain | B30.2/SPRY | 4.75e-03 | 95 | 133 | 4 | IPR001870 | |
| Domain | B302_SPRY | 4.75e-03 | 95 | 133 | 4 | PS50188 | |
| Domain | PRY | 4.83e-03 | 48 | 133 | 3 | SM00589 | |
| Domain | LDLRA_1 | 4.83e-03 | 48 | 133 | 3 | PS01209 | |
| Domain | PRY | 4.83e-03 | 48 | 133 | 3 | IPR006574 | |
| Domain | LDrepeatLR_classA_rpt | 5.12e-03 | 49 | 133 | 3 | IPR002172 | |
| Domain | LDLa | 5.12e-03 | 49 | 133 | 3 | SM00192 | |
| Domain | LDLRA_2 | 5.12e-03 | 49 | 133 | 3 | PS50068 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 2.44e-09 | 9 | 104 | 5 | MM14527 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 4.15e-08 | 6 | 104 | 4 | M47468 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 9.62e-08 | 7 | 104 | 4 | M47582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 9.62e-08 | 7 | 104 | 4 | M47530 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 1.57e-07 | 18 | 104 | 5 | MM14525 | |
| Pathway | BIOCARTA_CTL_PATHWAY | 2.82e-07 | 20 | 104 | 5 | MM1374 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 8.87e-07 | 11 | 104 | 4 | M525 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 9.37e-07 | 25 | 104 | 5 | MM15713 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 9.37e-07 | 25 | 104 | 5 | MM1465 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.32e-06 | 12 | 104 | 4 | M47529 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 7.74e-06 | 98 | 104 | 7 | M965 | |
| Pathway | BIOCARTA_LIS1_PATHWAY | 9.95e-06 | 19 | 104 | 4 | M22005 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA | 2.13e-05 | 8 | 104 | 3 | M47955 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | HLA-A HLA-B HLA-C TRIM35 HLA-G HLA-H NUP62 PDE12 TRIM17 EIF4E3 | 3.31e-05 | 273 | 104 | 10 | M983 |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 4.31e-05 | 27 | 104 | 4 | MM15053 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 4.71e-05 | 54 | 104 | 5 | MM14871 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 4.99e-05 | 28 | 104 | 4 | M924 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 5.76e-05 | 29 | 104 | 4 | M1062 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 8.18e-05 | 12 | 104 | 3 | M27326 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.34e-04 | 14 | 104 | 3 | MM15052 | |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 1.53e-04 | 37 | 104 | 4 | M18615 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 2.13e-04 | 74 | 104 | 5 | MM15962 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 2.29e-04 | 41 | 104 | 4 | M13519 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 2.42e-04 | 76 | 104 | 5 | MM15051 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 2.42e-04 | 76 | 104 | 5 | MM14526 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 2.73e-04 | 78 | 104 | 5 | M973 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 2.77e-04 | 43 | 104 | 4 | M12617 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 2.94e-04 | 18 | 104 | 3 | M614 | |
| Pathway | KEGG_ENDOCYTOSIS | 3.82e-04 | 181 | 104 | 7 | M1519 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 4.30e-04 | 86 | 104 | 5 | M916 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 5.77e-04 | 52 | 104 | 4 | M13103 | |
| Pathway | WP_PROTEASOME_DEGRADATION | 7.65e-04 | 56 | 104 | 4 | MM15901 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 1.11e-03 | 7 | 104 | 2 | MM1566 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 1.11e-03 | 7 | 104 | 2 | M22049 | |
| Pathway | WP_PROTEASOME_DEGRADATION | 1.12e-03 | 62 | 104 | 4 | M39639 | |
| Pathway | WP_TAR_SYNDROME | 1.19e-03 | 63 | 104 | 4 | M48082 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 1.47e-03 | 8 | 104 | 2 | MM14717 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 1.76e-03 | 70 | 104 | 4 | M12294 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 1705528 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 2808323 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 21088134 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 69663 | ||
| Pubmed | Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. | 1.71e-11 | 7 | 135 | 5 | 12459592 | |
| Pubmed | Multiple sequences related to classical histocompatibility antigens in the mouse genome. | 1.71e-11 | 7 | 135 | 5 | 6264319 | |
| Pubmed | Sequence analysis of the C3H H-2K1k gene: relationship to the H-2 loci. | 1.71e-11 | 7 | 135 | 5 | 2714856 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 10500200 | ||
| Pubmed | Structural analysis of H-2Kf and H-2Kfm1 by using H-2K locus-specific sequences. | 1.71e-11 | 7 | 135 | 5 | 2391419 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 15671142 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 14215561 | ||
| Pubmed | A saturation hypothesis to explain both enhanced and impaired learning with enhanced plasticity. | 1.71e-11 | 7 | 135 | 5 | 28234229 | |
| Pubmed | Interaction of H-2Db with mutant histocompatibility gene H (KH-11) in the mouse. | 1.71e-11 | 7 | 135 | 5 | 6242891 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 17512611 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 7018573 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 2642506 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 9037062 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 1840571 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 20957233 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 11580250 | ||
| Pubmed | V beta T cell repertoire of CD8+ splenocytes selected on nonpolymorphic MHC class I molecules. | 1.71e-11 | 7 | 135 | 5 | 11086076 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 12750360 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 18416856 | ||
| Pubmed | Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire. | 1.71e-11 | 7 | 135 | 5 | 20974936 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 10704462 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 22573867 | ||
| Pubmed | A novel H-2K splice form: predictions for other alternative H-2 splicing events. | 1.71e-11 | 7 | 135 | 5 | 2908875 | |
| Pubmed | Comparison of exon 5 sequences from 35 class I genes of the BALB/c mouse. | 1.71e-11 | 7 | 135 | 5 | 2584927 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 3496275 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 12147629 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 3458188 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 19462379 | ||
| Pubmed | Structural diversity of the classical H-2 genes: K, D, and L. | 1.71e-11 | 7 | 135 | 5 | 1730883 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 3680952 | ||
| Pubmed | Thymus leukemia antigen controls intraepithelial lymphocyte function and inflammatory bowel disease. | 1.71e-11 | 7 | 135 | 5 | 19004778 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 6300887 | ||
| Pubmed | H-2-linked regulation of xenotropic murine leukemia virus expression. | 1.71e-11 | 7 | 135 | 5 | 6300850 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 8500526 | ||
| Pubmed | cDNA clone coding for part of a mouse H-2d major histocompatibility antigen. | 1.71e-11 | 7 | 135 | 5 | 6265910 | |
| Pubmed | Cutting edge: MHC class I-Ly49 interaction regulates neuronal function. | 1.71e-11 | 7 | 135 | 5 | 18453559 | |
| Pubmed | DNA polymorphisms defined by the Tu108 probe map to the Tla region of mouse chromosome 17. | 1.71e-11 | 7 | 135 | 5 | 2906539 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 3013627 | ||
| Pubmed | DNA sequence of the mouse H-2Dd transplantation antigen gene. | 1.71e-11 | 7 | 135 | 5 | 3856254 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 3894562 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 27385590 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 1348042 | ||
| Pubmed | H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning. | 1.71e-11 | 7 | 135 | 5 | 19346486 | |
| Pubmed | Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. | 1.71e-11 | 7 | 135 | 5 | 18383043 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 16272298 | ||
| Pubmed | Tissue-specific expression of an unusual H-2 (class I)-related gene. | 1.71e-11 | 7 | 135 | 5 | 6956903 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 8833240 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 21178009 | ||
| Pubmed | Expression and function of transplantation antigens with altered or deleted cytoplasmic domains. | 1.71e-11 | 7 | 135 | 5 | 6604582 | |
| Pubmed | Isolation of a cDNA clone for the murine transplantation antigen H-2Kb. | 1.71e-11 | 7 | 135 | 5 | 6954478 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 34525366 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 3374494 | ||
| Pubmed | Extensive deletions in the Q region of the mouse major histocompatibility complex. | 1.71e-11 | 7 | 135 | 5 | 3025084 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 2543831 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 2989712 | ||
| Pubmed | Unique biochemical properties of a mutant MHC class I molecule, H-2Ksm1. | 1.71e-11 | 7 | 135 | 5 | 1280760 | |
| Pubmed | Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes. | 1.71e-11 | 7 | 135 | 5 | 6786753 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 6583704 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 6571712 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 9222352 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 12006653 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 1699529 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 17982076 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 7520098 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 15644207 | ||
| Pubmed | How a single T cell receptor recognizes both self and foreign MHC. | 1.71e-11 | 7 | 135 | 5 | 17418792 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 9185075 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 21483793 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 10452993 | ||
| Pubmed | Intestinal epithelial cells modulate CD4 T cell responses via the thymus leukemia antigen. | 1.71e-11 | 7 | 135 | 5 | 21900182 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 15272181 | ||
| Pubmed | Genetic control of scrapie and Creutzfeldt-Jakob disease in mice. | 1.71e-11 | 7 | 135 | 5 | 6408182 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 26714929 | ||
| Pubmed | Partial nucleotide sequence of H-2Dd major histocompatibility antigen gene. | 1.71e-11 | 7 | 135 | 5 | 3925012 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 6280871 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 10799615 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 10993729 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 1339405 | ||
| Pubmed | H-2D(b-/-) mice are susceptible to persistent infection by Theiler's virus. | 1.71e-11 | 7 | 135 | 5 | 10823851 | |
| Pubmed | MHC class I Dk locus and Ly49G2+ NK cells confer H-2k resistance to murine cytomegalovirus. | 1.71e-11 | 7 | 135 | 5 | 19454713 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 10229092 | ||
| Pubmed | Comparison of nucleotide sequences of mRNAs belonging to the mouse H-2 multigene family. | 1.71e-11 | 7 | 135 | 5 | 6278432 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 7295646 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 2879284 | ||
| Pubmed | Structure and expression of a mouse major histocompatibility antigen gene, H-2Ld. | 1.71e-11 | 7 | 135 | 5 | 6952248 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 24064213 | ||
| Pubmed | Developmental Sculpting of Intracortical Circuits by MHC Class I H2-Db and H2-Kb. | 1.71e-11 | 7 | 135 | 5 | 25316337 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 7306483 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 2903482 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 28475642 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 2351932 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 17240452 | ||
| Pubmed | Nucleotide sequence analysis of H-2Df and the spontaneous in vivo H-2Dfm2 mutation. | 1.71e-11 | 7 | 135 | 5 | 1731192 | |
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 1627536 | ||
| Pubmed | 1.71e-11 | 7 | 135 | 5 | 32341060 | ||
| Pubmed | H-2 class I and Gt (H-2) antigens are identical: evidence from H-2 mutant mice. | 1.71e-11 | 7 | 135 | 5 | 2422118 | |
| Interaction | HLA-H interactions | 8.60e-10 | 17 | 133 | 6 | int:HLA-H | |
| Interaction | LILRB1 interactions | 3.69e-07 | 10 | 133 | 4 | int:LILRB1 | |
| Interaction | LILRB2 interactions | 3.69e-07 | 10 | 133 | 4 | int:LILRB2 | |
| Interaction | TAP2 interactions | 2.95e-06 | 94 | 133 | 7 | int:TAP2 | |
| Interaction | CAV1 interactions | HLA-A HLA-C NTRK1 MCAM GPRIN3 LRP8 LGALS9 USP5 STRN TRIM67 GRK2 NISCH UNC5C LRP1 MACF1 TNKS1BP1 | 2.34e-05 | 724 | 133 | 16 | int:CAV1 |
| Interaction | CD8A interactions | 2.42e-05 | 26 | 133 | 4 | int:CD8A | |
| Interaction | ATF7IP interactions | 3.68e-05 | 138 | 133 | 7 | int:ATF7IP | |
| Interaction | ASAP1 interactions | 4.72e-05 | 98 | 133 | 6 | int:ASAP1 | |
| Interaction | CNNM4 interactions | 5.56e-05 | 62 | 133 | 5 | int:CNNM4 | |
| Interaction | LRRCC1 interactions | 5.65e-05 | 32 | 133 | 4 | int:LRRCC1 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 2.03e-06 | 44 | 86 | 5 | 588 | |
| GeneFamily | ATPases Ca2+ transporting | 8.55e-06 | 9 | 86 | 3 | 1209 | |
| GeneFamily | Low density lipoprotein receptors | 2.87e-05 | 13 | 86 | 3 | 634 | |
| GeneFamily | C1-set domain containing | 4.65e-05 | 42 | 86 | 4 | 591 | |
| GeneFamily | Fibronectin type III domain containing | 1.15e-04 | 160 | 86 | 6 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.19e-04 | 161 | 86 | 6 | 593 | |
| GeneFamily | Keratins, type I | 3.12e-04 | 28 | 86 | 3 | 608 | |
| GeneFamily | Immunoglobulin like domain containing | 2.28e-03 | 193 | 86 | 5 | 594 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.02e-03 | 206 | 86 | 5 | 682 | |
| GeneFamily | Gap junction proteins | 4.86e-03 | 22 | 86 | 2 | 314 | |
| GeneFamily | Phosphodiesterases | 5.77e-03 | 24 | 86 | 2 | 681 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 1.40e-08 | 16 | 135 | 5 | MM3766 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 3.69e-08 | 19 | 135 | 5 | MM797 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 | 3.69e-08 | 19 | 135 | 5 | MM862 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_CORTEX_ARTERY_CELL_AGEING | 4.74e-08 | 39 | 135 | 6 | MM3725 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 4.90e-08 | 20 | 135 | 5 | MM3682 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 6.41e-08 | 21 | 135 | 5 | MM651 | |
| Coexpression | HU_GENOTOXIC_DAMAGE_4HR | 8.70e-08 | 43 | 135 | 6 | MM1204 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING | 1.32e-07 | 24 | 135 | 5 | MM3773 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 1.65e-07 | 25 | 135 | 5 | MM672 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING | 5.13e-07 | 31 | 135 | 5 | MM3729 | |
| Coexpression | PAL_PRMT5_TARGETS_DN | 9.65e-07 | 35 | 135 | 5 | MM674 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | RMND5B UAP1 HLA-A HLA-B HLA-C KRT33A KRT33B KRT34 GJB6 POLR2A HLA-G HLA-H RETREG3 NHSL1 ATP2A2 | 1.64e-06 | 659 | 135 | 15 | MM1040 |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 1.68e-06 | 39 | 135 | 5 | MM3758 | |
| Coexpression | HOWLIN_CITED1_TARGETS_1_UP | 2.17e-06 | 41 | 135 | 5 | MM710 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_TYPE_II_PNEUMOCYTE_AGEING | 3.11e-06 | 44 | 135 | 5 | MM3775 | |
| Coexpression | HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN | 3.11e-06 | 44 | 135 | 5 | MM805 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOCARDIAL_CELL_AGEING | 3.89e-06 | 46 | 135 | 5 | MM3712 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | UAP1 HLA-A HLA-B HLA-C KRT33A KRT33B KRT34 POLR2A HLA-G HLA-H KPNA6 RETREG3 ATP2A2 FERMT3 | 4.91e-06 | 630 | 135 | 14 | MM1038 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | PRTG RELN MYLK KALRN BAZ2B SLC2A14 RETREG3 LGALS9 TYRO3 NHSL1 STRN FBXO10 TULP4 NISCH NCAN TBC1D14 MASTL KIF13A MINDY1 | 5.17e-06 | 1124 | 135 | 19 | MM1070 |
| Coexpression | BAUS_TFF2_TARGETS_UP | 5.35e-06 | 49 | 135 | 5 | MM1287 | |
| Coexpression | MIKKELSEN_MCV6_ICP_WITH_H3K27ME3 | 5.60e-06 | 86 | 135 | 6 | MM834 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING | 5.92e-06 | 50 | 135 | 5 | MM3805 | |
| Coexpression | CASTELLANO_NRAS_TARGETS_UP | 6.40e-06 | 88 | 135 | 6 | MM1087 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_NAIVE_T_CELL_AGEING | 7.20e-06 | 52 | 135 | 5 | MM3808 | |
| Coexpression | COATES_MACROPHAGE_M1_VS_M2_DN | 7.29e-06 | 90 | 135 | 6 | MM750 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2C | RELN MYLK NLGN4Y LRP1B SLC6A9 TRIM67 NCAN OSBPL6 LRP1 SPAG17 | 7.50e-06 | 325 | 135 | 10 | M39053 |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_FENESTRATED_CELL_AGEING | 7.77e-06 | 91 | 135 | 6 | MM3720 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 8.81e-06 | 93 | 135 | 6 | MM1185 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_KERATINOCYTE_AGEING | 1.04e-05 | 56 | 135 | 5 | MM3852 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_SMOOTH_MUSCLE_CELL_AGEING | 1.14e-05 | 57 | 135 | 5 | MM3716 | |
| Coexpression | HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR | 1.24e-05 | 58 | 135 | 5 | MM661 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_INTERNEURON_AGEING | 1.35e-05 | 59 | 135 | 5 | MM3688 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_ENDOCARDIAL_CELL_AGEING | 1.35e-05 | 59 | 135 | 5 | MM3704 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE | 1.43e-05 | 211 | 135 | 8 | MM17081 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | PRTG RELN MYLK KALRN BAZ2B RETREG3 LGALS9 TYRO3 NHSL1 STRN FBXO10 TULP4 NISCH NCAN TBC1D14 MASTL KIF13A MINDY1 | 1.49e-05 | 1102 | 135 | 18 | M2369 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN | 1.59e-05 | 103 | 135 | 6 | MM476 | |
| Coexpression | YU_MYC_TARGETS_DN | 2.70e-05 | 68 | 135 | 5 | MM632 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_VENTRICULAR_MYOCYTE_AGEING | 3.77e-05 | 120 | 135 | 6 | MM3710 | |
| Coexpression | GAURNIER_PSMD4_TARGETS | 3.82e-05 | 73 | 135 | 5 | M11428 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_GRANULOCYTE_AGEING | 4.08e-05 | 74 | 135 | 5 | MM3796 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | RELN MYLK SLC2A14 MCAM CARD10 FJX1 EXT1 OSBPL6 LRP1 GOLIM4 ATP2A2 | 4.27e-05 | 483 | 135 | 11 | MM1082 |
| Coexpression | TABULA_MURIS_SENIS_LUNG_NK_CELL_AGEING | 4.35e-05 | 75 | 135 | 5 | MM3759 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_BRUSH_CELL_AGEING | 4.35e-05 | 75 | 135 | 5 | MM3718 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_BASAL_CELL_AGEING | 4.60e-05 | 322 | 135 | 9 | MM3786 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_UP | 5.04e-05 | 185 | 135 | 7 | MM1072 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_B_CELL_AGEING | 6.68e-05 | 82 | 135 | 5 | MM3777 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_MACROPHAGE_AGEING | 6.68e-05 | 82 | 135 | 5 | MM3858 | |
| Coexpression | DURAND_STROMA_NS_UP | 6.80e-05 | 194 | 135 | 7 | MM962 | |
| Coexpression | GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 7.49e-05 | 197 | 135 | 7 | M8980 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP | 7.50e-05 | 84 | 135 | 5 | MM1049 | |
| Coexpression | ZHANG_UTERUS_C6_ENDOTHELIAL_PLVAP_HIGH_CELL | 7.90e-05 | 137 | 135 | 6 | MM16612 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_DN | 8.23e-05 | 200 | 135 | 7 | M3635 | |
| Coexpression | GSE5589_UNSTIM_VS_45MIN_LPS_STIM_MACROPHAGE_UP | 8.23e-05 | 200 | 135 | 7 | M6597 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 8.86e-05 | 87 | 135 | 5 | MM652 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_B_CELL_AGEING | 1.04e-04 | 90 | 135 | 5 | MM3756 | |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 1.12e-04 | 146 | 135 | 6 | MM856 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SMOOTH_MUSCLE_CELL_AGEING | 1.16e-04 | 92 | 135 | 5 | MM3748 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_MONOCYTE_AGEING | 1.16e-04 | 147 | 135 | 6 | MM3707 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN | HLA-A BAZ2B SLC2A14 KPNA6 KDM5D ADAM12 PDE12 NISCH LRP1 RCOR3 PROB1 CPLANE1 CFAP46 | 1.31e-04 | 746 | 135 | 13 | M40863 |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_NK_CELL_AGEING | 1.41e-04 | 96 | 135 | 5 | MM3834 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_MACROPHAGE_AGEING | 1.48e-04 | 97 | 135 | 5 | MM3789 | |
| Coexpression | HOLLERN_MICROACINAR_BREAST_TUMOR_UP | 1.50e-04 | 52 | 135 | 4 | MM968 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_OVERLAP_UP | 1.56e-04 | 98 | 135 | 5 | MM460 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN | 1.57e-04 | 222 | 135 | 7 | MM1132 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_BRONCHIAL_SMOOTH_MUSCLE_CELL_AGEING | 1.61e-04 | 156 | 135 | 6 | MM3763 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_RENCA_UP | 1.71e-04 | 100 | 135 | 5 | MM458 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | HLA-A HLA-B HLA-C MTHFD2 HLA-G HLA-H NUP62 ADAM12 TYRO3 TRIM17 CTPS1 | 1.87e-04 | 571 | 135 | 11 | MM1100 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 1.95e-04 | 479 | 135 | 10 | M2573 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_PROMONOCYTE_AGEING | 2.06e-04 | 104 | 135 | 5 | MM3812 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_BLADDER_UROTHELIAL_CELL_AGEING | 2.11e-04 | 164 | 135 | 6 | MM3680 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_B_CELL_AGEING | 2.79e-04 | 111 | 135 | 5 | MM3831 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOTHELIAL_CELL_OF_CORONARY_ARTERY_AGEING | 2.94e-04 | 246 | 135 | 7 | MM3713 | |
| Coexpression | ZHANG_UTERUS_C9_DENDRITIC_CELL | 3.15e-04 | 114 | 135 | 5 | MM16615 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_HEMATOPOIETIC_PRECURSOR_CELL_AGEING | 3.15e-04 | 114 | 135 | 5 | MM3799 | |
| Coexpression | SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_UP | 3.19e-04 | 26 | 135 | 3 | M41741 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | RMND5B UAP1 HLA-A HLA-B KRT33A KRT34 GJB6 POLR2A RETREG3 NHSL1 ATP2A2 | 3.52e-04 | 615 | 135 | 11 | M8673 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP | HLA-A HLA-B HLA-C KALRN HLA-G HLA-H SLC2A14 FJX1 RETREG3 SLC6A9 CTPS1 | 3.57e-04 | 616 | 135 | 11 | MM977 |
| Coexpression | LIN_NPAS4_TARGETS_UP | 3.81e-04 | 183 | 135 | 6 | MM767 | |
| Coexpression | KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN | 3.90e-04 | 6 | 135 | 2 | M7182 | |
| Coexpression | SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_PRE_TREATMENT_UP | 4.43e-04 | 29 | 135 | 3 | M41740 | |
| Coexpression | RIGGI_EWING_SARCOMA_PROGENITOR_UP | 4.51e-04 | 437 | 135 | 9 | M15981 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_UP | 4.53e-04 | 533 | 135 | 10 | M10791 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_DISTAL_CONVOLUTED_TUBULE_EPITHELIAL_CELL_AGEING | 4.64e-04 | 124 | 135 | 5 | MM3726 | |
| Coexpression | KIM_LRRC3B_TARGETS | 4.90e-04 | 30 | 135 | 3 | M17363 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_UP | 4.91e-04 | 192 | 135 | 6 | MM752 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_CARDIOMYOCYTE_AGEING | 4.99e-04 | 126 | 135 | 5 | MM3711 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_VALVE_CELL_AGEING | 4.99e-04 | 126 | 135 | 5 | MM3709 | |
| Coexpression | MA_RAT_AGING_UP | 5.17e-04 | 127 | 135 | 5 | MM16096 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_FIBROBLAST_AGEING | 5.17e-04 | 127 | 135 | 5 | MM3856 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_MESENCHYMAL_STEM_CELL_AGEING | 5.47e-04 | 196 | 135 | 6 | MM3746 | |
| Coexpression | GSE24814_STAT5_KO_VS_WT_PRE_BCELL_UP | 5.62e-04 | 197 | 135 | 6 | M8426 | |
| Coexpression | GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 5.62e-04 | 197 | 135 | 6 | M8983 | |
| Coexpression | GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_UP | 5.62e-04 | 197 | 135 | 6 | M7682 | |
| Coexpression | GSE14308_TH2_VS_TH17_DN | 5.93e-04 | 199 | 135 | 6 | M3363 | |
| Coexpression | GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_UP | 5.93e-04 | 199 | 135 | 6 | M8080 | |
| Coexpression | GSE27786_CD8_TCELL_VS_NEUTROPHIL_DN | 5.93e-04 | 199 | 135 | 6 | M4847 | |
| Coexpression | GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_UP | 5.93e-04 | 199 | 135 | 6 | M7252 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN | 5.93e-04 | 199 | 135 | 6 | M3912 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP | 5.93e-04 | 199 | 135 | 6 | M8848 | |
| Coexpression | GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_DN | 5.93e-04 | 199 | 135 | 6 | M5092 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-09 | 184 | 135 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-09 | 184 | 135 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-09 | 184 | 135 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.42e-08 | 181 | 135 | 8 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 9.16e-08 | 183 | 135 | 8 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.04e-07 | 186 | 135 | 8 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-07 | 195 | 135 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-06 | 177 | 135 | 7 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-06 | 177 | 135 | 7 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.17e-06 | 177 | 135 | 7 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.17e-06 | 177 | 135 | 7 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.17e-06 | 177 | 135 | 7 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.47e-06 | 183 | 135 | 7 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-06 | 185 | 135 | 7 | 487fa382232564f075960899d50afa0edae5d258 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.75e-06 | 188 | 135 | 7 | 0501a8aa850bd2e347020abd1cac4d8075738189 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.88e-06 | 190 | 135 | 7 | 56cc761e50fddfb5366391518b4d8e16589b6b42 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.88e-06 | 190 | 135 | 7 | 25d4b591f75c26e404a34c42f1742d580af6598d | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-06 | 192 | 135 | 7 | 445985fe1bcd33e4f0a1704b27988fbfc9334538 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-06 | 193 | 135 | 7 | 5c6b03d6d98aa873fda1a201d44a912246bb5a92 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-06 | 193 | 135 | 7 | d4b58eee97043b4337ec36c40f9af6499d864df9 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 195 | 135 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.07e-06 | 152 | 135 | 6 | 9391b46a441cf031665df1d142e3f65e98675eeb | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.21e-05 | 167 | 135 | 6 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-05 | 169 | 135 | 6 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-05 | 173 | 135 | 6 | 0ba64e5385fe714f876002520f8b5202809bf11e | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-05 | 177 | 135 | 6 | 7c3d46ebd7e8726be6871aa9763e281fc0ec6ac8 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-05 | 177 | 135 | 6 | e7b1f3092e6b8d0d580f82648035f5ad12be6961 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-B_cells-Pro-B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.79e-05 | 179 | 135 | 6 | 223f0895da89c7606f637aef113912dd06f39c5a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.79e-05 | 179 | 135 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-05 | 183 | 135 | 6 | a90ffd9c50caa65f537a2e441e37655e1b622327 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-05 | 183 | 135 | 6 | 13ad20ec140ef5b96fdace3369b5befc0f40bb76 | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 2.09e-05 | 184 | 135 | 6 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.16e-05 | 185 | 135 | 6 | 79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 185 | 135 | 6 | 9438097e94219c1db922b8507e3a29106d32a923 | |
| ToppCell | LV-07._Pericyte|LV / Chamber and Cluster_Paper | 2.16e-05 | 185 | 135 | 6 | acb38eba871ec72f2a8136a33b87d33b8c85465d | |
| ToppCell | RV-07._Pericyte|RV / Chamber and Cluster_Paper | 2.22e-05 | 186 | 135 | 6 | c533b264fbe12bc35467486fc7fbde24ba968fe1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.29e-05 | 187 | 135 | 6 | 698ae9eefa8ba97fea8ea61e4e868edd194de03b | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Endo|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.29e-05 | 187 | 135 | 6 | ed8816433d1086a634892502898255b487a2d4a7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.29e-05 | 187 | 135 | 6 | 02105c82a9ba79d2f19e002188377fc3440770c2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.29e-05 | 187 | 135 | 6 | d8b09398400a178b03e641af1476c4dac0c6e82a | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 2.36e-05 | 188 | 135 | 6 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.43e-05 | 189 | 135 | 6 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | wk_08-11-Endothelial-Lymph_endothelial-Lymphatic_endo|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.51e-05 | 190 | 135 | 6 | 279c5f68b993dc7adbf9aa69fffb1321cdebc48a | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-05 | 190 | 135 | 6 | 251e3a33041023bfc4b547c7eb68cfb8f421636f | |
| ToppCell | wk_08-11-Endothelial-Lymph_endothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.51e-05 | 190 | 135 | 6 | d7f1dc032d161529559e01832d1a3112c6f6cc1a | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 2.58e-05 | 191 | 135 | 6 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.58e-05 | 191 | 135 | 6 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.66e-05 | 192 | 135 | 6 | 4e63d95f75fe6eb3f817e84528883e95093c5bbd | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.66e-05 | 192 | 135 | 6 | 0afb9dbe468e0be442c326e11c5fc0f699b32f23 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.74e-05 | 193 | 135 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.74e-05 | 193 | 135 | 6 | b7c0b4dbbe11f86cff6371d3d12a6b772b938d78 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.74e-05 | 193 | 135 | 6 | e44d777f65b907f299cefd73296805ac4c92d383 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.74e-05 | 193 | 135 | 6 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.74e-05 | 193 | 135 | 6 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 2.82e-05 | 194 | 135 | 6 | 777ce41c3f22c591e2d81120f189b834e53ffb4b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.82e-05 | 194 | 135 | 6 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.98e-05 | 196 | 135 | 6 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.98e-05 | 196 | 135 | 6 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | normal-na-Lymphocytic_NK-T_mait|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.07e-05 | 197 | 135 | 6 | 5abe983f9750085ec7b57bcb8c36bdfe78a6ee4c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.07e-05 | 197 | 135 | 6 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.07e-05 | 197 | 135 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | normal-na-Lymphocytic_NK-T_mait-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.07e-05 | 197 | 135 | 6 | 8752c0f37979aa7bf2e8aee6990fb6307a6666b7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.16e-05 | 198 | 135 | 6 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | wk_20-22|World / Celltypes from embryonic and fetal-stage human lung | 3.16e-05 | 198 | 135 | 6 | 56eb765773a1a27a44262a447df7cfae8a9db90d | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells-Megakaryocyte|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 3.16e-05 | 198 | 135 | 6 | 8cedd6ae249ac1c08441b90901a8bb2360feba17 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.25e-05 | 199 | 135 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.34e-05 | 200 | 135 | 6 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-TYR-L2-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.34e-05 | 200 | 135 | 6 | 04954fbe1e2264077228bb582c9a5897a70e6da2 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.34e-05 | 200 | 135 | 6 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.34e-05 | 200 | 135 | 6 | c1797542541747b524c9c22c723d24c8d027d486 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-PCDH20-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.34e-05 | 200 | 135 | 6 | 1d67c5d2c617749b521e70879950dea2c9d076d6 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-TYR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.34e-05 | 200 | 135 | 6 | bfdafb024a7b20d46837b2e6480dd4929253cd62 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-CHRNA4-L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.34e-05 | 200 | 135 | 6 | e2ced6eb1de9a526c34c7558b9c637854916e624 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.34e-05 | 200 | 135 | 6 | 53d5e427f0cbf5cf0b63efe4ec01da302f555704 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.34e-05 | 200 | 135 | 6 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.34e-05 | 200 | 135 | 6 | a0cc84add181109bb66ba9d49c732e1790222c96 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 3.34e-05 | 200 | 135 | 6 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 3.34e-05 | 200 | 135 | 6 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-CHRNA4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.34e-05 | 200 | 135 | 6 | 9bc924755e5a4c464408e6103b86bf1b4e8c58b5 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-PCDH20|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.34e-05 | 200 | 135 | 6 | 26c7f2b0afe9e50f2a5c43918ad8e91d7553b72c | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Kctd12|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.28e-05 | 64 | 135 | 4 | 2edc3ae3e334bb04a411778e3b102b3a84a97824 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Kctd12-Inhibitory_Gad1Gad2Slc17a8_Htr3a.Ktcd12_(Interneuron,__GABA/Glutamate_co-releasing?_(candidate_CGE-derived_9))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.28e-05 | 64 | 135 | 4 | b8aac6e83c2e5b09b55ea22ddb29940099f186e1 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Kctd12-Inhibitory_Gad1Gad2Slc17a8_Htr3a.Ktcd12_(Interneuron,__GABA/Glutamate_co-releasing?_(candidate_CGE-derived_9))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.28e-05 | 64 | 135 | 4 | 3e3eed30abcecd3fc8d30489dca05222ac353180 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.78e-05 | 130 | 135 | 5 | 60e28d452d0e2af768459ba8dbe998117c94a251 | |
| ToppCell | IIH-CD4-CD8_2|IIH / Condition, Cell_class and T cell subcluster | 6.14e-05 | 137 | 135 | 5 | 5614a086f5f698e0965f3c7699cffefec5c3b87e | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Cpa6_Gpr88|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.28e-05 | 142 | 135 | 5 | 84742a7e35bab09ee1cca80cfe120b613d6aed6a | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6_(Thalamus,_glutamatergic)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.58e-05 | 74 | 135 | 4 | ef4c9eafc794c7d50aef28b37d21b52d3c511499 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6_(Thalamus,_glutamatergic)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.58e-05 | 74 | 135 | 4 | 6ecbdf4186039a031410e09ecd5afa66b6d5e2dc | |
| ToppCell | Ciliated_cells-B-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 9.13e-05 | 149 | 135 | 5 | 6399c5a2f06d79f020dece252526f1c0c110d569 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.13e-05 | 149 | 135 | 5 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.43e-05 | 150 | 135 | 5 | 53de595376a9fc92491dfd58ff25938b0bf79903 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.43e-05 | 150 | 135 | 5 | e4b40b3243ed26d0c46bf196ac06e148834e7ed2 | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial-epithelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.73e-05 | 151 | 135 | 5 | 0de76acd1b204345dce7f33be2a1ed9fbe9e6da0 | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.73e-05 | 151 | 135 | 5 | 20b9c8fb966c5d62ff909cc4a4616b109b78cdca | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.73e-05 | 151 | 135 | 5 | bee48137d1f5f27a24571a59c835284651d38538 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|Lung / Manually curated celltypes from each tissue | 9.73e-05 | 151 | 135 | 5 | 9bfb807e1180b31fa9a2c500ce993de9707c070f | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.10e-04 | 155 | 135 | 5 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.24e-04 | 159 | 135 | 5 | 7f29f9dcf25ffa1822b137c571e9ac16defc6292 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 160 | 135 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 160 | 135 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| Computational | Genes in the cancer module 293. | 1.49e-06 | 12 | 82 | 4 | MODULE_293 | |
| Computational | Genes in the cancer module 143. | 2.97e-06 | 14 | 82 | 4 | MODULE_143 | |
| Computational | Neighborhood of INPP5D | 3.10e-04 | 43 | 82 | 4 | GNF2_INPP5D | |
| Computational | Neighborhood of HLA-C | 4.37e-04 | 47 | 82 | 4 | GNF2_HLA_C | |
| Computational | Neighborhood of PTPN6 | 4.37e-04 | 47 | 82 | 4 | GNF2_PTPN6 | |
| Drug | 2,5-dimethylquinone | 3.78e-07 | 11 | 135 | 4 | CID000008718 | |
| Drug | AC1L88YH | 2.65e-06 | 17 | 135 | 4 | CID000374551 | |
| Drug | caged ATP | 3.73e-06 | 70 | 135 | 6 | CID000123806 | |
| Drug | C13932 | 3.99e-06 | 206 | 135 | 9 | CID000168297 | |
| Drug | AC1L380G | 4.28e-06 | 19 | 135 | 4 | CID000084698 | |
| Drug | AC1L25Y6 | 9.59e-06 | 23 | 135 | 4 | CID000015465 | |
| Drug | Tetramisole hydrochloride [16595-80-5]; Up 200; 16.6uM; PC3; HT_HG-U133A | 2.36e-05 | 197 | 135 | 8 | 4587_UP | |
| Drug | ATP-EDC | 2.37e-05 | 10 | 135 | 3 | CID000195647 | |
| Drug | 1sqc | 2.37e-05 | 10 | 135 | 3 | CID000444279 | |
| Drug | Hexetidine [141-94-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.45e-05 | 198 | 135 | 8 | 5420_DN | |
| Drug | 2-methyl-3-pentanone | 3.49e-05 | 2 | 135 | 2 | CID000011265 | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 1.29e-08 | 7 | 131 | 4 | DOID:0081267 (implicated_via_orthology) | |
| Disease | Brody myopathy (implicated_via_orthology) | 8.55e-08 | 3 | 131 | 3 | DOID:0050692 (implicated_via_orthology) | |
| Disease | Schizophrenia | RELN HLA-A HLA-B HLA-C NTRK1 ADAM12 RGS12 LRP8 SLC6A9 TGM2 WDR11 NCAN UNC5C LRP1 ATP2A2 | 9.31e-06 | 883 | 131 | 15 | C0036341 |
| Disease | beta-2 microglobulin measurement | 1.37e-05 | 11 | 131 | 3 | EFO_0005197 | |
| Disease | Malignant Glioma | 1.53e-05 | 70 | 131 | 5 | C0555198 | |
| Disease | mixed gliomas | 1.53e-05 | 70 | 131 | 5 | C0259783 | |
| Disease | – | 1.96e-05 | 2 | 131 | 2 | 608579 | |
| Disease | Susceptibility to severe cutaneous adverse reaction | 1.96e-05 | 2 | 131 | 2 | cv:C1840548 | |
| Disease | Carbamazepine response | 1.96e-05 | 2 | 131 | 2 | cv:CN077964 | |
| Disease | Manic | 2.60e-05 | 78 | 131 | 5 | C0338831 | |
| Disease | Glioma | 4.41e-05 | 87 | 131 | 5 | C0017638 | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 6.65e-05 | 18 | 131 | 3 | EFO_0006831, EFO_0006896 | |
| Disease | Stevens-Johnson syndrome (is_implicated_in) | 1.17e-04 | 4 | 131 | 2 | DOID:0050426 (is_implicated_in) | |
| Disease | allergic asthma (is_implicated_in) | 1.94e-04 | 5 | 131 | 2 | DOID:9415 (is_implicated_in) | |
| Disease | asthma, Eczema | 1.94e-04 | 5 | 131 | 2 | HP_0000964, MONDO_0004979 | |
| Disease | platelet-to-lymphocyte ratio | 2.26e-04 | 363 | 131 | 8 | EFO_0008446 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 2.54e-04 | 126 | 131 | 5 | EFO_0004611, EFO_0010351 | |
| Disease | Manic Disorder | 2.86e-04 | 71 | 131 | 4 | C0024713 | |
| Disease | Drug-Induced Stevens Johnson Syndrome | 2.87e-04 | 29 | 131 | 3 | C1274933 | |
| Disease | Mycoplasma-Induced Stevens-Johnson Syndrome | 2.87e-04 | 29 | 131 | 3 | C3658301 | |
| Disease | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 2.87e-04 | 29 | 131 | 3 | C3658302 | |
| Disease | Toxic Epidermal Necrolysis | 2.87e-04 | 29 | 131 | 3 | C0014518 | |
| Disease | Stevens-Johnson Syndrome | 3.18e-04 | 30 | 131 | 3 | C0038325 | |
| Disease | body fat percentage | 3.43e-04 | 488 | 131 | 9 | EFO_0007800 | |
| Disease | Disorder of eye | 3.80e-04 | 212 | 131 | 6 | C0015397 | |
| Disease | Depression, Bipolar | 4.31e-04 | 79 | 131 | 4 | C0005587 | |
| Disease | tyrosine-protein kinase receptor TYRO3 measurement | 5.38e-04 | 8 | 131 | 2 | EFO_0020829 | |
| Disease | mean platelet volume | NRDC HLA-B NRF1 HLA-C KALRN POLR2A XRCC2 RGS12 TRMU STRN TBC1D14 FERMT3 NIN | 6.29e-04 | 1020 | 131 | 13 | EFO_0004584 |
| Disease | heart disease (implicated_via_orthology) | 6.44e-04 | 38 | 131 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | Nephritis | 6.90e-04 | 9 | 131 | 2 | C0027697 | |
| Disease | uveal melanoma (is_marker_for) | 6.90e-04 | 9 | 131 | 2 | DOID:6039 (is_marker_for) | |
| Disease | fish oil supplement exposure measurement, triglyceride measurement | 8.60e-04 | 10 | 131 | 2 | EFO_0004530, EFO_0600007 | |
| Disease | S-warfarin measurement | 9.34e-04 | 97 | 131 | 4 | EFO_0803323 | |
| Disease | coronary artery disease (is_implicated_in) | 1.05e-03 | 100 | 131 | 4 | DOID:3393 (is_implicated_in) | |
| Disease | complement C1q tumor necrosis factor-related protein 5 measurement | 1.05e-03 | 11 | 131 | 2 | EFO_0801494 | |
| Disease | Paranoia | 1.05e-03 | 11 | 131 | 2 | C1456784 | |
| Disease | platelet crit | HLA-A HLA-B NRF1 KALRN MCAM APOC3 ADGRV1 FAM13B TULP4 NCAN RCOR3 CTPS1 | 1.12e-03 | 952 | 131 | 12 | EFO_0007985 |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 1.25e-03 | 12 | 131 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | cervical carcinoma | 1.34e-03 | 182 | 131 | 5 | EFO_0001061 | |
| Disease | heel bone mineral density, urate measurement | 1.34e-03 | 182 | 131 | 5 | EFO_0004531, EFO_0009270 | |
| Disease | Bipolar Disorder | 1.35e-03 | 477 | 131 | 8 | C0005586 | |
| Disease | complex trait | 1.36e-03 | 271 | 131 | 6 | EFO_0010578 | |
| Disease | cortical thickness | PRTG RELN HLA-B EXT1 ADGRV1 ADAM12 LRP8 NHSL1 STRN UMODL1 LRP1 MACF1 KIF13A | 1.39e-03 | 1113 | 131 | 13 | EFO_0004840 |
| Disease | lower face morphology measurement | 1.44e-03 | 109 | 131 | 4 | EFO_0010948 | |
| Disease | apolipoprotein A 1 measurement | MGAM HLA-B HLA-G APOC3 TYRO3 WDR11 LRP1 MACF1 TNKS1BP1 EIF4E3 MINDY1 | 1.44e-03 | 848 | 131 | 11 | EFO_0004614 |
| Disease | basophil count | 1.46e-03 | 483 | 131 | 8 | EFO_0005090 | |
| Disease | complement C4 measurement | 1.61e-03 | 52 | 131 | 3 | EFO_0004984 | |
| Disease | parental longevity | 1.68e-03 | 494 | 131 | 8 | EFO_0007796 | |
| Disease | Drug habituation | 1.75e-03 | 115 | 131 | 4 | C0013170 | |
| Disease | Drug abuse | 1.75e-03 | 115 | 131 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.75e-03 | 115 | 131 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 1.75e-03 | 115 | 131 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 1.75e-03 | 115 | 131 | 4 | C0013222 | |
| Disease | Drug Dependence | 1.75e-03 | 115 | 131 | 4 | C1510472 | |
| Disease | Substance Dependence | 1.75e-03 | 115 | 131 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 1.75e-03 | 115 | 131 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.75e-03 | 115 | 131 | 4 | C0029231 | |
| Disease | Substance abuse problem | 1.81e-03 | 116 | 131 | 4 | C0740858 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.95e-03 | 291 | 131 | 6 | EFO_0008317, EFO_0020946 | |
| Disease | killer cell immunoglobulin-like receptor 2DS2 measurement | 1.98e-03 | 15 | 131 | 2 | EFO_0801746 | |
| Disease | cystatin C measurement | 2.18e-03 | 402 | 131 | 7 | EFO_0004617 | |
| Disease | eosinophil count | HLA-A HLA-B HLA-C HLA-G APOC3 PTGFRN MDN1 TBC1D14 BTN2A3P VWA3B TNKS1BP1 EIF4E3 ATP2A3 BBC3 ANKRD33B | 2.54e-03 | 1488 | 131 | 15 | EFO_0004842 |
| Disease | Eye Abnormalities | 2.55e-03 | 17 | 131 | 2 | C0015393 | |
| Disease | glycochenodeoxycholate measurement | 2.55e-03 | 17 | 131 | 2 | EFO_0010490 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 2.59e-03 | 128 | 131 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 2.59e-03 | 128 | 131 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 2.59e-03 | 128 | 131 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 2.59e-03 | 128 | 131 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 2.59e-03 | 128 | 131 | 4 | C0007134 | |
| Disease | HIV viral set point measurement | 2.80e-03 | 63 | 131 | 3 | EFO_0006319 | |
| Disease | serum IgE measurement | 2.92e-03 | 64 | 131 | 3 | EFO_0004579 | |
| Disease | facial attractiveness measurement | 3.18e-03 | 19 | 131 | 2 | EFO_0009892 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 3.18e-03 | 222 | 131 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 3.37e-03 | 225 | 131 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | autism spectrum disorder, schizophrenia | 3.47e-03 | 327 | 131 | 6 | EFO_0003756, MONDO_0005090 | |
| Disease | COVID-19 (is_implicated_in) | 3.89e-03 | 21 | 131 | 2 | DOID:0080600 (is_implicated_in) | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 3.95e-03 | 144 | 131 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | opioid dependence | 4.20e-03 | 237 | 131 | 5 | EFO_0005611 | |
| Disease | Hodgkin Disease | 4.26e-03 | 22 | 131 | 2 | C0019829 | |
| Disease | Takayasu arteritis | 4.35e-03 | 148 | 131 | 4 | EFO_1001857 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 4.35e-03 | 148 | 131 | 4 | C0279702 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 4.35e-03 | 239 | 131 | 5 | EFO_0008317, EFO_0020945 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FQIDRQGTRVQDWDE | 496 | Q5DID0 | |
| FEQITNAWVQVSGDE | 141 | A8MVM7 | |
| ENVIEWTVGICRDNV | 361 | Q96KV6 | |
| VRGEEEQWAREIGAQ | 126 | Q9BXH1 | |
| EEEQLQQARWRAGES | 481 | Q8N715 | |
| DDNGEIRIWNVSNGE | 1146 | O14727 | |
| AVQGELQWAEELRDQ | 341 | Q9BWT7 | |
| WVVAVLQEVAAAAAQ | 836 | Q14203 | |
| QNEEGTDHVEVAWRR | 251 | Q6L9W6 | |
| NQVTRDIVENWSVEE | 1776 | Q9UIF8 | |
| EVSWEAVELDVNNIN | 396 | Q96GX5 | |
| NSDNETAQIWIEGVV | 196 | O75388 | |
| ITENVIRENQWGGVD | 591 | Q9UK96 | |
| IIDANDGARGVIEWQ | 2951 | Q8WXG9 | |
| EIGQEIQEAWIVQNA | 726 | Q8IYW2 | |
| VSLWNQGRADEVVSA | 31 | O43184 | |
| RQLWAAVQAQDVATV | 1056 | Q99490 | |
| EEQQLGNLEARWEVE | 46 | Q8N7U9 | |
| RPEQVTWAAQEQELE | 321 | O60826 | |
| NAIVGVWQERNAENA | 101 | O14983 | |
| NAIVGVWQERNAESA | 101 | Q93084 | |
| FVRLWVNQEDEVEEG | 61 | O43307 | |
| RWQQEVAETVFDTIN | 516 | P25098 | |
| VDVNWQDSEGNTALI | 146 | A6NCL7 | |
| NLEEVLQEWEAEQGT | 336 | Q9P2K3 | |
| LSNEENIETERWNGR | 471 | Q9H4I0 | |
| EITLTWQRDGEDQTQ | 236 | P01893 | |
| EPQRQWQEEVAAVVV | 6 | Q9H477 | |
| EIILTWQRDGEDQTQ | 236 | P17693 | |
| WQRDGEDQTQDVELV | 241 | P17693 | |
| EDVQEQAVWALGNIA | 181 | O60684 | |
| WAENDVGRAEVSVQV | 266 | P04629 | |
| PADGDVAAQWVEVQR | 26 | Q96FN9 | |
| EAWNSAGEVRTQAVL | 696 | Q15746 | |
| VTLGEWVERTQQLQD | 3096 | Q9NU22 | |
| DNWEDRQVIVENVGS | 2256 | Q9NZR2 | |
| LNQDGTVWVTAVQAV | 346 | O75648 | |
| RDQTWREDVVTNGIG | 1951 | Q07954 | |
| VVVNGSLDWDSQVEL | 1361 | O43451 | |
| DVVVNGSLDWDSQVE | 2256 | O43451 | |
| AVVRNTQIDNSWGSE | 276 | O00182 | |
| FQVNGNAETVEWLRQ | 61 | Q9NYF5 | |
| AQAWIADVDEIQNGD | 1016 | Q9BY66 | |
| SVCGQQVEVDDENWI | 46 | Q5SYE7 | |
| EITLTWQRDGEDQTQ | 236 | P10321 | |
| SSWAVQVSQGNREVE | 36 | Q6UW60 | |
| AVAEDVLNVDAWQDG | 131 | Q6L8Q7 | |
| EFWEQGDLERTVLQQ | 741 | P16499 | |
| VANEFWEQGDLERTV | 741 | P51160 | |
| NEWGDQITNEIVRQM | 2531 | Q96JB1 | |
| EGQSRAITWEQFQVV | 426 | Q5H8C1 | |
| AWVQDINQVLETQRD | 2216 | O60229 | |
| VADGEVEQNWATLQG | 351 | Q16656 | |
| DQGFLQEEQVVWESL | 336 | Q8N5J2 | |
| QEEQVVWESLHNVDG | 341 | Q8N5J2 | |
| VETNRREVEQWFATQ | 236 | O76009 | |
| QDVGGWENETIVQRF | 1501 | P09848 | |
| TQVNAWDRTLIENGE | 356 | P37198 | |
| QRLWGTQDVSQDIQE | 251 | Q8TDB8 | |
| EITLTWQRDGEDQTQ | 236 | P01889 | |
| VIDANQREAWVSNDT | 901 | Q9BZF3 | |
| REDVVQVWNVNASLV | 171 | Q8N5X7 | |
| QVWNVNASLVGEATV | 176 | Q8N5X7 | |
| EALQWVVGTEVEIIN | 5256 | Q9UPN3 | |
| IVVSGVERAQWALDN | 3031 | P78509 | |
| VRWQQDVEDTAAIQG | 636 | Q2VWP7 | |
| TREVQEVSRNNDVWQ | 276 | O00461 | |
| VQWQAQEVVAQARLD | 66 | Q9Y3R4 | |
| EARGAQWAQVQEELR | 216 | Q86VR8 | |
| DQIQALRWIEENVGA | 226 | Q8NFZ3 | |
| NAIVGVWQERNAENA | 101 | P16615 | |
| RVGDQWEEEQSLASQ | 256 | P0C671 | |
| VINWNQAAVIGDERL | 371 | Q16394 | |
| SEWQLQQEAAEALVG | 286 | Q8IXT2 | |
| RVQRNIGSFEVNIWE | 1421 | Q9H799 | |
| VLGVAAEDVWNDEQS | 36 | P57773 | |
| QAAGVVIEDWRAQVG | 1931 | Q9Y6R7 | |
| CQAAGVVIEDWRAQV | 3131 | Q9Y6R7 | |
| LVVAAQEVWGDEQED | 36 | O95452 | |
| AEGWEELEQQEAEVQ | 366 | Q6ZU35 | |
| QAQGQWVQVGRTEVV | 51 | Q9UBL6 | |
| AEAARVQEQDLRQWG | 26 | Q86WJ1 | |
| EITLTWQRDGEDQTQ | 236 | P04439 | |
| NIWLVRGSEQDVVID | 31 | Q68D91 | |
| QEVGVNAENVWSDCI | 411 | Q8NA82 | |
| QTENQEIGWDSEALV | 86 | Q6ZVS7 | |
| EVPSRAWQDAEVQAV | 311 | Q6ZVF9 | |
| DQIQALRWIEENVGA | 226 | Q8N0W4 | |
| DHIWTNGENEINAEI | 426 | Q8NG08 | |
| NGVDRQTLVSDNIEW | 571 | Q14114 | |
| QDLEFQWLREETGQV | 371 | P43121 | |
| AQLVEQWVGLTEERN | 1131 | Q9H1H9 | |
| QGNWQEIQEKAVEVA | 256 | Q9P2B2 | |
| ERAQWEVERAELQAQ | 66 | O43815 | |
| NQVEAAWLEGRIRQE | 176 | Q9UPQ4 | |
| NRREVEQWFATQTEE | 281 | O76011 | |
| LDTWQEEGIENSQEI | 311 | Q8N4C6 | |
| QEVRQEVEEWVASGN | 51 | P13995 | |
| ANGVEINREQWIQDA | 496 | O94906 | |
| IVERDFQWTDNTGLQ | 1151 | O14594 | |
| VQDLANGNITWADVE | 706 | P41250 | |
| VVEFSRNVLGWQDAN | 406 | P17812 | |
| DQEQDIVLQGQWIER | 511 | Q9P2P6 | |
| EWENQNPAVEETVSR | 436 | E7EW31 | |
| WVIENHGVEQRLEEQ | 166 | Q15126 | |
| DWQASIAFVVGNQIE | 31 | Q6Q759 | |
| QESQVAQQARGWVTD | 51 | P02656 | |
| SGSWERDQQVEAAQR | 26 | Q86VR2 | |
| EVNADVVDWIQQDDG | 396 | P21980 | |
| VEESIGNAVLTWNNE | 366 | Q9P2M4 | |
| WSVELVNDRGAQVSD | 116 | Q9NRJ4 | |
| RVQVSQEQWVKGALE | 466 | Q6ZTA4 | |
| EDVTVNFTQGEWQRL | 11 | Q96PE6 | |
| EEQQRRIWAALEQAE | 521 | Q6NZY4 | |
| EDVAVTFTQEEWGQL | 16 | Q14592 | |
| TFTQEEWGQLDVTQR | 21 | Q14592 | |
| DGVAVSAVAQQVLWN | 1866 | Q8N2C7 | |
| EGTAQIWKRQSQEVE | 1311 | O14924 | |
| SDAVWDAREQQQQIL | 106 | Q96G75 | |
| ALVQDRQEAPWNEVD | 121 | Q5VZP5 | |
| PQSTVVAEDQEWVNV | 1181 | P24928 | |
| LGTQRSQEADVQDWE | 831 | Q9C0C2 | |
| WIEAANQREEGQGEQ | 621 | Q9Y2I1 | |
| HLGEEVDRNWNEVVT | 1031 | O43847 | |
| VTAIVDEVGNEWILQ | 481 | P48067 | |
| NVNWDIRQVAIEFDE | 601 | Q86UX7 | |
| ENALVWIAVNEDGVS | 1241 | Q9ULM0 | |
| TRDQDQLQAWESEGL | 81 | Q16222 | |
| WIDRVNGGESVNLQE | 156 | O43543 | |
| GNLQAREEQSLAEWQ | 161 | Q9Y577 | |
| GDIRDVNTNSENWAV | 956 | Q9H6S0 | |
| WVRAQEPESGEQAVA | 101 | Q96IT1 | |
| GWQVDQAILSEEDRV | 11 | P83876 | |
| GQAVAWREQLAEVNE | 551 | Q502W6 | |
| IVWDVAAGVAQCEIQ | 96 | Q9BZH6 | |
| GQWEDVVVVGEENFT | 631 | O95185 | |
| SRKQEVQAWDGEVRQ | 161 | P45974 | |
| NQRIGEWELIQESGV | 301 | P45974 | |
| SWVQDNGTQDELTVE | 361 | Q06418 | |
| FTQEEWGQLDLVQRT | 71 | Q8WXB4 | |
| EVEAILNGDVNFQVW | 286 | Q9HCX4 | |
| VETNRREVEQWFATQ | 236 | Q14525 | |
| FREEDAGEWITVNQT | 851 | P54296 | |
| RWVTVQVQGQEVLSE | 131 | P28698 |